Wnt Pathway Activation Predicts Increased Risk of Tumor Recurrence in Patients With Stage I Nonsmall Cell Lung Cancer

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis

(2009) Don X. Nguyen et al.   CELL

New TNM classification for non-small-cell lung cancer

(2009) Lynn T Tanoue et al.   Expert Review of Anticancer Therapy

Risk of Recurrence of Resected Stage I Non-small Cell Lung Cancer in Elderly Patients as Compared with Younger Patients

(2009) Boone Goodgame et al.   Journal of Thoracic Oncology

Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma

(2009) G Akiri et al.   ONCOGENE

Early Recurrence after Surgical Resection in Patients with Pathological Stage I Non-small Cell Lung Cancer

(2009) R. Kawachi et al.   THORACIC AND CARDIOVASCULAR SURGEON

Wnt1 overexpression promotes tumour progression in non-small cell lung cancer

(2008) Cheng-Long Huang et al.   EUROPEAN JOURNAL OF CANCER

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

(2008) Jean-Pierre Pignon et al.   JOURNAL OF CLINICAL ONCOLOGY

Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression

(2008) Qiang Wei et al.   LUNG CANCER